Sunmax Biotechnology Co., Ltd. (4728) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sunmax Biotechnology Co., Ltd. (4728:TWSE), powered by AI.

Current Price
$375.50
Sector
Healthcare
What is the Sunmax Biotechnology Co., Ltd. stock price forecast?

Sunmax Biotechnology Co., Ltd. is currently trading at $375.50. View real-time AI analysis on Alpha Lenz.

What is Sunmax Biotechnology Co., Ltd. insider trading activity?

View the latest insider trading data for Sunmax Biotechnology Co., Ltd. on Alpha Lenz.

What is Sunmax Biotechnology Co., Ltd.'s P/E ratio?

View Sunmax Biotechnology Co., Ltd.'s valuation metrics on Alpha Lenz.

Sunmax Biotechnology Co., Ltd.

TWSE · 4728
NT$375.50+0.50(+0.13%)
Ask about Sunmax Biotechnology Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Sunmax Biotechnology Co., Ltd.'s ROE is 46.4%. Explore profitability and growth together.

Ask for details

Company Overview

Sunmax Biotechnology Co., Ltd. is a biomedical company specializing in the development, manufacturing, and commercialization of collagen-based medical devices and bio-surgical products. Established in 2001 and headquartered in Tainan, Taiwan, its core offerings focus on medical products and biomedical materials for both therapeutic and aesthetic applications, including dermal fillers, absorbable collagen membranes, dental bone grafts, and collagen bone fillers. The company's product lines also extend to skincare solutions such as moisturizing creams and facial masks, primarily leveraging biomedical-grade collagen for enhanced efficacy. Sunmax targets the healthcare and biotechnology sectors, with solutions utilized in medical procedures, cosmetic treatments, and dental surgeries. Its products, often branded under the Sunmax name, are distributed across Taiwan, Mainland China, and various international markets. Renowned for strong profitability metrics and robust returns on capital, Sunmax Biotechnology plays a significant role in advancing medical specialties by delivering high-quality collagen implants and materials tailored for both clinical and consumer health needs.

SectorHealthcare
IndustryBiotechnology
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$2.03BRevenue
0.00Shares Out
0Employees

Margins

78.41%Gross
55.39%EBITDA
49.27%Operating
50.07%Pre-Tax
35.82%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

13.11%Rev 3Yr
18.81%Rev 5Yr
9.15%Op Inc 3Yr
24.79%Op Inc 5Yr
10.78%Net Inc 3Yr
24.97%Net Inc 5Yr

Returns

36.52%ROA
46.36%ROE
51.31%ROIC

Financial Health

NT$711.59MCash & Cash Equivalents
NT$-205.99MNet Debt
31.25%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Sunmax Biotechnology Co., Ltd. (ticker: 4728) is a company listed on TWSE in the Healthcare sector (Biotechnology).

The current price is 375.5 with a P/E ratio of -x and P/B of -x.

ROE is 46.36% and operating margin is 49.27%. Annual revenue is $2.0B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Sunmax Biotechnology Co., Ltd. (4728) Stock Forecast 2026 $375.50 — Price, Financials & Analyst Targets | Alpha Lenz